Stefano Del Prato

Research interests

Publications

• Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetes Care · 2022 · 10.2337/dci22-0034

• Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

  The Lancet Diabetes & Endocrinology · 2022 · 10.1016/s2213-8587(22)00319-9

• Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetologia · 2022 · 10.1007/s00125-022-05787-2

• Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)02188-7

• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

  The Lancet Diabetes & Endocrinology · 2021 · 10.1016/s2213-8587(21)00203-5

• Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

  New England Journal of Medicine · 2021 · 10.1056/nejmoa2108269

• COVID-19 in people with diabetes: understanding the reasons for worse outcomes

  The Lancet Diabetes & Endocrinology · 2020 · 10.1016/s2213-8587(20)30238-2

• New-Onset Diabetes in Covid-19

  New England Journal of Medicine · 2020 · 10.1056/nejmc2018688

• Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32261-x

• Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32261-x

• Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

  Diabetes Care · 2016 · 10.2337/dc16-0236

• Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

  The Lancet · 2013 · 10.1016/s0140-6736(13)62154-6

• 'European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)' The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). [Eur Heart J 2012;33:1635-1701, doi: 10.1093/eurheartj/ehs092]

  European Heart Journal · 2012 · 10.1093/eurheartj/ehs254

• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

  European Heart Journal · 2012 · 10.1093/eurheartj/ehs092

• Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin

  Diabetes Care · 2011 · 10.2337/dc11-0606

• The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia

  Diabetes Obesity and Metabolism · 2011 · 10.1111/j.1463-1326.2011.01511.x

• Management of type 2 diabetes: new and future developments in treatment

  The Lancet · 2011 · 10.1016/s0140-6736(11)60207-9

• How Do We Define Cure of Diabetes?

  Diabetes Care · 2009 · 10.2337/dc09-9036

• Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion

  Diabetologia · 2008 · https://doi.org/10.1007/s00125-007-0916-5

• Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

  Journal of Clinical Investigation · 2007 · https://doi.org/10.1172/jci30706

• Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

  Proceedings of the National Academy of Sciences · 2007 · https://doi.org/10.1073/pnas.0700442104

• Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients

  Diabetologia · 2005 · 10.1007/s00125-004-1627-9

• Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes

  Diabetes · 2005 · https://doi.org/10.2337/diabetes.54.3.727

• Intermediate metabolism in normal pregnancy and in gestational diabetes

  Diabetes/Metabolism Research and Reviews · 2003 · 10.1002/dmrr.390

• Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets

  Diabetes · 2002 · https://doi.org/10.2337/diabetes.51.5.1437

Current projects

No projects listed.